These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29961005)

  • 1. Equity and efficiency in the scaled-up implementation of integrated neglected tropical disease control: the health economics protocol of the COUNTDOWN multicountry observational study in Ghana, Cameroon and Liberia.
    Woode ME; Khan JAM; Thomson R; Niessen LW;
    BMJ Open; 2018 Jun; 8(6):e020113. PubMed ID: 29961005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benchmarking the Cost per Person of Mass Treatment for Selected Neglected Tropical Diseases: An Approach Based on Literature Review and Meta-regression with Web-Based Software Application.
    Fitzpatrick C; Fleming FM; Madin-Warburton M; Schneider T; Meheus F; Asiedu K; Solomon AW; Montresor A; Biswas G
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005037. PubMed ID: 27918573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease control priorities for neglected tropical diseases: lessons from priority ranking based on the quality of evidence, cost effectiveness, severity of disease, catastrophic health expenditures, and loss of productivity.
    Strømme EM; Baerøe K; Norheim OF
    Dev World Bioeth; 2014 Dec; 14(3):132-41. PubMed ID: 23724925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neglected tropical diseases: comparison of the costs of integrated and vertical preventive chemotherapy treatment in Niger.
    Leslie J; Garba A; Boubacar K; Yayé Y; Sebongou H; Barkire A; Fleming FM; Mounkaila I; Adamou S; Jackou ML
    Int Health; 2013 Mar; 5(1):78-84. PubMed ID: 24029850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the cost-effectiveness of integrated case management of Neglected Tropical Diseases in Liberia.
    Godwin-Akpan TG; Diaconu K; Edmiston M; Smith JS; Sosu F; Weiland S; Kollie KK
    BMC Health Serv Res; 2023 Jun; 23(1):705. PubMed ID: 37386431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases.
    Redekop WK; Lenk EJ; Luyendijk M; Fitzpatrick C; Niessen L; Stolk WA; Tediosi F; Rijnsburger AJ; Bakker R; Hontelez JA; Richardus JH; Jacobson J; de Vlas SJ; Severens JL
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005289. PubMed ID: 28103243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage of preventive measures and surveillance for neglected tropical diseases in hard-to-reach communities in Ghana.
    Forson AO; Awuah RB; Mohammed AR; Owusu-Asenso CM; Akosah-Brempong G; Abdulai A; Sraku IK; Dhikrullahi SB; Atakora SB; Attah SK; Afrane YA
    BMC Public Health; 2023 Sep; 23(1):1784. PubMed ID: 37710219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the neglected tropical disease mass drug administration campaign approach an effective strategy to deliver universal health coverage? A case study of the Liberia neglected tropical disease programme.
    Tate A; Kollie K; Senyonjo L; Sturrock H; Downs P; Bush S; Bedell A; Molyneux D
    Int Health; 2024 May; 16(3):283-292. PubMed ID: 37191201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study.
    De Neve JW; Andriantavison RL; Croke K; Krisam J; Rajoela VH; Rakotoarivony RA; Rambeloson V; Schultz L; Qamruddin J; Verguet S
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007002. PubMed ID: 30589847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving equity in UHC interventions: who is left behind by neglected tropical disease programmes in Cameroon?
    Christine Masong M; Ozano K; Tagne MS; Tchoffo MN; Ngang S; Thomson R; Theobald S; Tchuenté LT; Kouokam E
    Glob Health Action; 2021 Jan; 14(1):1886457. PubMed ID: 33641612
    [No Abstract]   [Full Text] [Related]  

  • 11. The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa.
    Immurana M; Kisseih KG; Abdullahi I; Azuug M; Manyeh AK; Mohammed A; Kizhakkekara TJM
    BMC Infect Dis; 2024 May; 24(1):462. PubMed ID: 38698313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of mass drug administration for neglected tropical diseases in Guinea during the COVID-19 pandemic.
    Sakho F; Badila CF; Dembele B; Diaby A; Camara AK; Lamah L; Reid SD; Weng A; Fuller BB; Sanchez KA; Kabore A; Zhang Y; Weaver A
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009807. PubMed ID: 34570807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of findings from the literature and a qualitative research study on the impacts of gender, disability, and ethnicity in Neglected Tropical Diseases programs.
    Arney JK; Headland MK; Bertone AM; Meite A; Ettiegne-Traore V; Asemanyi-Mensah K; Dede Teiko Dzathor I; Kargbo-Labour I; Jalloh U; Houck P; Stukel D
    PLoS Negl Trop Dis; 2023 Dec; 17(12):e0011782. PubMed ID: 38048347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the cost of engage & treat and test & treat strategies towards the elimination of lymphatic filariasis in Ghana.
    Adams NNK; Ahorlu CS; de Souza DK; Aikins M
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012213. PubMed ID: 38787898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison.
    Collyer BS; Turner HC; Hollingsworth TD; Keeling MJ
    Parasit Vectors; 2019 Oct; 12(1):499. PubMed ID: 31647019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing mass drug administration adherence and community drug distributor opportunity costs in Liberia: a mixed-methods approach.
    Agboraw E; Sosu F; Dean L; Siakeh A; Thomson R; Kollie K; Worrall E
    Parasit Vectors; 2021 Oct; 14(1):557. PubMed ID: 34711278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community drug distributors for mass drug administration in neglected tropical disease programmes: systematic review and analysis of policy documents.
    Macfarlane CL; Dean L; Thomson R; Garner P
    J Glob Health; 2019 Dec; 9(2):020414. PubMed ID: 31662849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?
    Turner HC; Stolk WA; Solomon AW; King JD; Montresor A; Molyneux DH; Toor J
    BMJ Glob Health; 2021 Aug; 6(8):. PubMed ID: 34385158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of integrated mass drug administration for neglected tropical diseases in Haiti.
    Goldman AS; Brady MA; Direny A; Desir L; Oscard R; Vely JF; Linehan M; Baker M
    Am J Trop Med Hyg; 2011 Nov; 85(5):826-33. PubMed ID: 22049035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethiopia and its steps to mobilize resources to achieve 2020 elimination and control goals for neglected tropical diseases webs joined can tie a lion.
    Mengitsu B; Shafi O; Kebede B; Kebede F; Worku DT; Herero M; French M; Kebede B; Mackenzie C; Martindale S; Kebede Z; Hirpa T; Frawley H; Crowley K; O'Neil M; McPherson S
    Int Health; 2016 Mar; 8 Suppl 1():i34-52. PubMed ID: 26940308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.